EVALUATION OF DRUG-DRUG INTERACTIONS TO INFORM DRUG USE

被引：0
|
作者：
Zhang, Lei [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2018年 / 33卷 / 01期
关键词：
PREDICTION;
D O I：
10.1016/j.dmpk.2017.11.020
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SC4.1
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [41] Preclinical evaluation of new drug-drug interactions of lomitapide: A proposal for novel mechanism of interaction associated with lipid metabolic changes
    Ito, Sayo M.
    Yamanashi, Yoshihide
    Suzuki, Hiroshi
    Takada, Tappei
    BIOCHEMICAL PHARMACOLOGY, 2025, 233
  • [42] Pharmacokinetics-Pharmacodynamics Modeling for Evaluating Drug-Drug Interactions in Polypharmacy: Development and Challenges
    Zhao, Di
    Huang, Ping
    Yu, Li
    He, Yu
    CLINICAL PHARMACOKINETICS, 2024, 63 (07) : 919 - 944
  • [43] Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions
    Yin, Hang
    Wang, Zhe
    Wang, Xiaoyu
    Lv, Xin
    Fan, Xiaoyu
    Yan, Mingrui
    Jia, Yanyan
    Jiang, Lili
    Cao, Jun
    Liu, Yong
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (11)
  • [44] Impact of Hepatic Uptake Transporters on Pharmacokinetics and Drug-Drug Interactions: Use of Assays and Models for Decision Making in the Pharmaceutical Industry
    Soars, Mathew G.
    Webborn, Peter J. H.
    Riley, Robert J.
    MOLECULAR PHARMACEUTICS, 2009, 6 (06) : 1662 - 1677
  • [45] Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessment
    Waters, Nigel J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (06) : 946 - 958
  • [46] Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling
    Granana-Castillo, Sandra
    Montanha, Maiara Camotti
    Bearon, Rachel
    Khoo, Saye
    Siccardi, Marco
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Assessment of community pharmacists' knowledge about drug-drug interactions in Jeddah, Saudi Arabia
    Alorfi, Nasser M.
    Alqurashi, Roaya S.
    Algarni, Alanood S.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 : 216 - 229
  • [49] DINTO: Using OWL Ontologies and SWRL Rules to Infer Drug-Drug Interactions and Their Mechanisms
    Herrero-Zazo, Maria
    Segura-Bedmar, Isabel
    Hastings, Janna
    Martinez, Paloma
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2015, 55 (08) : 1698 - 1707
  • [50] Drug-drug interaction prediction using PASS
    Dmitriev, A. V.
    Filimonov, D. A.
    Rudik, A. V.
    Pogodin, P. V.
    Karasev, D. A.
    Lagunin, A. A.
    Poroikov, V. V.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2019, 30 (09) : 655 - 664
12345